Advocacy
Awareness
Education
Research
How we reached the first ADPKD treatment
In light of our exciting news about tolvaptan receiving FDA approval as the first ADPKD treatment, we reached out to Benjamin Cowley Jr., M.D. to explain how we reached this amazing milestone. Dr. Cowley was on the Independent Data Monitoring Committee for the...
Breaking news: FDA approves first treatment for ADPKD
Today is a historic day in providing hope to patients with polycystic kidney disease. We are excited to announce that the U.S. Food and Drug Administration (FDA) granted approval of JYNARQUE™ (tolvaptan) to be the first treatment in the United States for adult...
PKD Foundation appoints past Fellowship recipient Michal Mrug, M.D., new Scientific Advisory Panel Chair
Meet Michal Mrug, M.D., Chair of the PKD Foundation Scientific Advisory Panel (SAP). The Scientific Advisory Panel is comprised of 14 of the most prestigious physicians and scientists in the United States investigating the causes of and treatments for PKD....
The reSEARCH for a cure
On our PKD journey, patients and researchers search for many answers, all with the common goal of discovering a cure. We patients may search to find out why we have this disease, what we can do to lead the healthiest lives, where we can obtain the best care or when...
-
In light of our exciting news about tolvaptan receiving FDA approval as the first ADPKD treatment, we reached out toRead More -
Today is a historic day in providing hope to patients with polycystic kidney disease. We are excited to announce thatRead More
-
Meet Michal Mrug, M.D., Chair of the PKD Foundation Scientific Advisory Panel (SAP). The Scientific Advisory Panel is comprised ofRead More
-
On our PKD journey, patients and researchers search for many answers, all with the common goal of discovering a cure.Read More
